Monteleone Berrin, Forster Katie, Chua Gin Nie, Zhang Rongrong, Lloyd Andrew, Castellano Paul, Tomazos Ioannis
Department of Pediatrics, NYU Long Island School of Medicine, Mineola, USA.
Acaster Lloyd Consulting, London, UK.
Health Qual Life Outcomes. 2025 Jan 23;23(1):7. doi: 10.1186/s12955-025-02335-5.
AADCd is a rare neurometabolic disorder presenting in infancy. Children with AADCd have motor dysfunction and development delays that result in the need for lifelong care; quality of life is greatly impacted. Current characterizations of health-related quality of life and associated health state utilities (HSUs) may be underestimated in AADCd. Accurate characterization of AADCd burden is important when evaluating the benefits of treatment, especially the improvements observed with the recently approved disease-modifying therapy eladocagene exuparvovec. Time-trade-off (TTO) vignette methods may be used to elicit HSUs in AADCd for assessing the value of new treatments. This study aimed to first update previously published health state vignettes, then estimate AADCd HSUs in the United States (US).
Existing vignettes for five AADCd health states were updated based on the review of published literature and clinician/caregiver input. Health states included: "bedridden/no motor function," "head control," "sitting unassisted," "standing with support," "walking with assistance." Online composite TTO interviews were conducted 1:1 with adults from the US general public. Participants ranked health states in order of preference using a visual analog scale, then were presented with health state vignettes to elicit utilities using TTO. Mean TTO scores were calculated for each health state, and regression models were used to estimate disutility associated with use of feeding tube.
Following revision of the vignettes, 120 participants completed the TTO task (mean age: 47 years; 50% female; 70% White); characteristics were not significantly different from US population norms in terms of age, sex, race or ethnicity. Six participants who appeared to misunderstand the exercise were excluded. Mean (SD) HSUs were: -0.258 (0.534) for bedridden state, -0.155 (0.569) for head control, 0.452 (0.523) for sitting unassisted, 0.775 (0.242) for standing with support, and 0.796 (0.235) for walking with assistance. The need for a feeding tube was associated with a disutility of 0.07.
This study implemented TTO methods to estimate utilities for five health states which reflect the burden and impact of AADCd. The range in values from the most to least severe health state suggests that there is potential for effective treatments to substantially improve quality of life in these patients.
芳香酸脱羧酶缺乏症(AADCd)是一种在婴儿期出现的罕见神经代谢紊乱疾病。患有AADCd的儿童存在运动功能障碍和发育迟缓,需要终身护理,生活质量受到极大影响。目前对与健康相关的生活质量和相关健康状态效用(HSU)的描述在AADCd中可能被低估。在评估治疗益处时,准确描述AADCd负担很重要,尤其是对于最近批准的疾病修饰疗法eladocagene exuparvovec所观察到的改善。时间权衡(TTO) vignette方法可用于得出AADCd中的HSU,以评估新治疗方法的价值。本研究旨在首先更新先前发表的健康状态vignette,然后估计美国AADCd的HSU。
根据已发表文献的综述以及临床医生/护理人员的意见,对五个AADCd健康状态的现有vignette进行了更新。健康状态包括:“卧床/无运动功能”、“头部控制”、“独立坐立”、“借助支撑站立”、“借助辅助行走”。与美国普通公众中的成年人进行了一对一的在线综合TTO访谈。参与者使用视觉模拟量表按偏好顺序对健康状态进行排序,然后展示健康状态vignette以使用TTO得出效用。计算每个健康状态的平均TTO得分,并使用回归模型估计与使用喂食管相关的负效用。
vignette修订后,120名参与者完成了TTO任务(平均年龄:47岁;50%为女性;70%为白人);在年龄、性别、种族或民族方面,其特征与美国人口规范无显著差异。排除了六名似乎误解该练习的参与者。平均(标准差)HSU分别为:卧床状态为-0.258(0.534),头部控制为-0.155(0.569),独立坐立为0.452(0.523),借助支撑站立为0.775(0.242),借助辅助行走为0.796(0.235)。使用喂食管与0.07的负效用相关。
本研究采用TTO方法来估计反映AADCd负担和影响的五个健康状态的效用。从最严重到最不严重健康状态的效用值范围表明,有效治疗有潜力显著改善这些患者的生活质量。